The Patent Finder

Melior Pharmaceuticals I, Inc.

Also on record
Records under this name other than the patents Melior Pharmaceuticals I, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Back to Melior Pharmaceuticals I, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,188,651Methods Of Treating Sleep Disorders
Held by another company
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
US 11,351,169Methods Of Treating Dyskinesia And Related Disorders
Held by another company
In force
 · High confidence
In forceHigh confidence
US 12,048,697Methods Of Treating Dyskinesia And Related Disorders
Held by another company
In force
 · High confidence
In forceHigh confidence
US 10,786,503Treatment Of Adipocytes
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,534,442Treatment Of Adipocytes
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,064,432Treatment Of Adipocytes
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 7,776,870Methods for modulating Lyn kinase activity and treating related disorders
Term ended
Term ended Aug 22, 2026 · USPTO record
Term endedTerm ended Aug 22, 2026USPTO record
US 8,343,985Methods for modulating Lyn kinase activity and treating related disorders
Term ended
Ended no later than Aug 22, 2026 · USPTO record
Term endedEnded no later than Aug 22, 2026USPTO record
US 8,835,448Methods and formulations for modulating lyn kinase activity and treating related disorders
Term ended
Ended no later than Aug 22, 2026 · USPTO record
Term endedEnded no later than Aug 22, 2026USPTO record
US 9,216,959Methods and formulations for treating cardiovascular disease
Term ended
Term ended Aug 22, 2026 · USPTO record
Term endedTerm ended Aug 22, 2026USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited